SSX2 and oligodendroglioma: SSX expression has also been evaluated by RT-PCR in brain tumors in which SSX1 was only expressed in astrocytomas, while SSX2 was expressed in astrocytomas and oligoastrocytomas, and SSX4 was expressed in both of these as well as oligodendrogliomas [92].